Search
Now showing items 1-10 of 29
Molecular Pathology of DMD
Year: 2004
Abstract:
1
The use of siRNA technology for the identification of differentially expressed genes in DMD: possible targets for gene thepray
Year: 2004
Abstract:
لطفا صفحه دو از فایل پیوست ملاحظه شود
The use of siRNA technology for identification of differentially expressed genes in Duchenne Muscular Dystrophy: Possible targets for gene therapy
Year: 2005
Abstract:
لطفا صفحه دو از فایل پیوست ملاحظه گردد
Potent Dystrophin Knockdown in vitro and in vivo using RNAi Technology and Expression Signature of Myotubes with dystrophin Knocked down
Year: 2005
Abstract:
Duchenne Muscular Dystrophy (DMD) is one of a group of genetically heterogeneous muscular dystrophies that are characterized by progressive weakness and wasting of skeletal muscle. Loss of myofibres occurs in response to a deficiency of dystrophin...
Potent Dystrophin Knockdown in vitro and in vivo and transcriptomic evaluation of dystrophin deficiency
Year: 2005
Abstract:
لطفا صفحه دو از فایل پیوست را ملاحظه فرمایند
Developmemnt of RNAi technique to Study DMD Molecular pathology
Year: 2003
Abstract:
لطفا صفحه دو از فایل پیوست ملاحظه گردد
Potent RNAi-mediated dystrophin knockdown in skeletal muscle cells in vitro and in vivo
Year: 2006
Abstract:
Duchenne muscular dystrophy (DMD) is a common inheritable human disease, caused by mutations in the dystrophin gene, the longest known human gene (~2.5Mb long), located on the short arm of X chromosome. DMD is clinically characterized by progressive...